Quirk Gerald E has filed 7 insider transactions across 1 company since March 2024.
Most recent transaction: a sale of 46657 shares of Syros Pharmaceuticals, Inc. ($SYRS) on November 19, 2024.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 19, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Quirk Gerald E | Chief Legal & Compliance Offic | S | Common Stock | 46657 | $0.22 | 0.0000 | 39,335,772 | 100.00% | 0.12% |
| Sept. 30, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Quirk Gerald E | Chief Legal & Compliance Offic | M | Common Stock | 10000 | $0.00 | 49,757.0000 | 28,325,779 | 25.15% | 0.04% |
| Sept. 30, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Quirk Gerald E | Chief Legal & Compliance Offic | F | Common Stock | 3100 | $2.10 | 46,657.0000 | 28,325,779 | 6.23% | 0.01% |
| Sept. 30, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Quirk Gerald E | Chief Legal & Compliance Offic | M | Restricted Stock Units | 10000 | $0.00 | 20,000.0000 | 28,325,779 | 33.33% | 0.04% |
| March 27, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Quirk Gerald E | Chief Legal & Compliance Offic | M | Common Stock | 22500 | $0.00 | 46,803.0000 | 28,325,779 | 92.58% | 0.08% |
| March 28, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Quirk Gerald E | Chief Legal & Compliance Offic | F | Common Stock | 7046 | $5.59 | 39,757.0000 | 28,325,779 | 15.05% | 0.02% |
| March 27, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Quirk Gerald E | Chief Legal & Compliance Offic | M | Restricted Stock Units | 22500 | $0.00 | 0.0000 | 28,325,779 | 100.00% | 0.08% |